Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
11.32B | 8.01B | 6.46B | 14.46B | 14.06B | Gross Profit |
8.81B | 6.14B | 5.14B | 3.78B | 2.61B | EBIT |
1.56B | 1.54B | 2.46B | 738.58M | 195.67M | EBITDA |
3.74B | 2.28B | 2.96B | 1.31B | 537.96M | Net Income Common Stockholders |
1.95B | 1.03B | 2.11B | 335.86M | 101.71M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.86B | 2.50B | 2.88B | 1.48B | 1.09B | Total Assets |
23.88B | 19.20B | 17.86B | 7.34B | 5.65B | Total Debt |
10.22B | 8.07B | 8.89B | 2.24B | 1.37B | Net Debt |
7.36B | 5.57B | 6.02B | 760.46M | 277.50M | Total Liabilities |
15.18B | 11.91B | 12.82B | 4.60B | 2.99B | Stockholders Equity |
7.89B | 7.25B | 4.99B | 2.72B | 2.66B |
Cash Flow | Free Cash Flow | |||
2.06B | 279.72M | 630.17M | 417.46M | -164.41M | Operating Cash Flow |
2.36B | 1.14B | 1.39B | 1.14B | 431.30M | Investing Cash Flow |
-1.15B | -831.13M | -5.97B | -1.27B | -1.46B | Financing Cash Flow |
-905.00M | -836.98M | 5.93B | 316.41M | 912.44M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ¥22.07B | 14.12 | ― | 41.30% | 127.51% | ||
61 Neutral | $14.55B | 5.92 | -3.82% | 8.36% | 2.79% | -33.24% | |
¥12.73B | 23.14 | 0.91% | ― | ― | |||
71 Outperform | ¥22.52B | 15.84 | 0.33% | -5.81% | 1585.94% | ||
¥14.40B | 9.04 | 1.90% | ― | ― | |||
66 Neutral | ¥7.83B | 13.27 | 4.22% | -2.17% | 25.33% | ||
44 Neutral | ¥7.58B | ― | 5.38% | 6.34% | -367.86% |